WASHINGTON — The Supreme Court on Tuesday tackles whether to maintain widely available access to the abortion pill mifepristone as it weighs a high-stakes challenge to the Food and Drug Administration's drug approval process. The court, which has a 6-3 conservative majority, hears oral arguments on the Biden administration's appeal of lower court rulings that restricted access to the pill, including its availability by mail.
The court in December took up the Biden administration's appeal in defense of the later FDA decisions, but it opted against hearing the challenge to the original approval of mifepristone in 2000. That issue is therefore not before the justices. The court will instead focus on the later FDA action, including the initial 2021 decision that made it available by mail, which was finalized last year.
Law Law Latest News, Law Law Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: NBCNews - 🏆 10. / 86 Read more »
Source: NBCNews - 🏆 10. / 86 Read more »
Source: NBCNews - 🏆 10. / 86 Read more »
Source: NBCNews - 🏆 10. / 86 Read more »
Source: NBCNews - 🏆 10. / 86 Read more »
Source: NBCNewsHealth - 🏆 707. / 51 Read more »